1. Cleavage of annexin I in human neutrophils is mediated by a membrane-localized metalloprotease.
- Author
-
Movitz C, Sjölin C, and Dahlgren C
- Subjects
- Amino Acid Sequence, Annexin A1 chemistry, Binding Sites, Calcium metabolism, Cytosol metabolism, Enzyme Inhibitors pharmacology, Humans, Metalloendopeptidases antagonists & inhibitors, Neutrophil Activation, Recombinant Proteins metabolism, Annexin A1 metabolism, Cell Membrane enzymology, Metalloendopeptidases metabolism, Neutrophils metabolism
- Abstract
A truncated form of annexin I, formed during Ca2+-induced translocation to neutrophil specific granules and secretory vesicles/plasma membranes, is generated through the action of an endogenous membrane protease. The cleavage of annexin I is inhibited by the metalloprotease inhibitor 1,10-phenanthroline as well as by Triton X-100 and dithiothreitol, classifying the protease as a membrane-bound, thiol-dependent metalloprotease. The cleavage site is located close to the N-terminal of annexin I, leaving a truncated form of the molecule, des1-8 annexin I, that contains the Ca2+-binding sites, as well as a number of phosphorylation sites of importance for the function of the protein. When assessing binding capacity to different neutrophil organelles, full-length annexin I bound to azurophil granules, specific granules, and secretory vesicles/plasma membranes, while des1-8 annexin I only bound to specific granules and secretory vesicles/plasma membranes, but not to azurophil granules (C. Sjölin, C. Dahlgren, Biochim. Biophys. Acta 1281 (1996) 227-234). This implies that there are different mechanisms of binding to neutrophil organelles of full-length annexin I and the truncated form, and that cleavage of annexin I might be of regulatory importance for the degranulation process.
- Published
- 1999
- Full Text
- View/download PDF